13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Cellular and Systems Neuroscience
The field of cellular and systems neuroscience bridges the gap between molecular neuroscience and behavioral neuroscience by exploring how individual cells and their connections in the brain give rise to complex functions. At the cellular level, research focuses on understanding the roles of neurons, glial cells, and synaptic interactions in maintaining brain homeostasis and supporting learning and memory processes. On a broader scale, systems neuroscience investigates how these cellular interactions form integrated networks that govern sensory perception, motor coordination, decision-making, and emotions. This knowledge is pivotal for comprehending how dysfunctions in these networks lead to neurological disorders such as Alzheimer's, autism, and stroke. By combining advanced techniques like single-cell RNA sequencing, neuroimaging, and computational modeling, this field is uncovering the dynamic relationships between cellular activities and systems-level behaviors.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States